Author

Na Li

Observed name: Na LI

Institutions: HUTCHMED (China) Limited (China), China Medical University

Observed institutions: Shenyang Pharmaceutical University, China Pharmaceutical University, State Key Laboratory of Natural Medicine, HUTCHMED (China) Limited (China), Zhejiang University of Technology, Henan Normal University, China Medical University

ORCID: 0009-0000-6687-549X

Observed ORCID: 0009-0000-6687-549X

OpenAlex ID: A5115883383

Discovery of Novel Anti-Breast-Cancer Inhibitors by Synergistically Antagonizing Microtubule Polymerization and Aryl Hydrocarbon Receptor Expression

2021 · Kun Wang, Hui Zhong, et al. · Journal of Medicinal Chemistry · 29

Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors

2023 · Na Li, Qi Guan, et al. · European Journal of Medicinal Chemistry · 21

Synthesis of pyrazolidinone fused cinnolines via the cascade reactions of 1-phenylpyrazolidinones with vinylene carbonate

2022 · Na Li, Xinying Zhang, et al. · Tetrahedron Letters · 15

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment

2025 · Kun Xiao, Zheng Zhang, et al. · ACS Medicinal Chemistry Letters · 11

Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response

2025 · Zhuo Wang, Wendong Guo, et al. · Cell Reports · 10

Asymmetric α-oxyamination of aldehydes by synergistic catalysis of imidazolethiones and metal salts

2014 · Xianrui Liang, Na Li, et al. · RSC Advances · 9

A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C)

2023 · Na LI, Chen-Fu Liu, et al. · Current Medicinal Chemistry · 8

ChemInform Abstract: Asymmetric α‐Oxyamination of Aldehydes by Synergistic Catalysis of Imidazolethiones and Metal Salts.

2015 · Xianrui Liang, Na Li, et al. · ChemInform

Works count: 8

Citation count: 103

H-index: 7

I10-index: 5